| Feb 10 2023 |
DOJ’s FCA Recoveries Were Lowest Level Since 2008 |
ArentFox Schiff LLP |
| Feb 10 2023 |
Proposed Universal Contraceptive Coverage in Response to Roe Reversal |
McDermott Will & Schulte LLP |
| Feb 10 2023 |
DEA Supports Elimination of X-Waiver Requirement for Prescribing of Buprenorphine |
McDermott Will & Schulte LLP |
| Feb 10 2023 |
Indiana Senate Approves Ban on Doctor Noncompete Agreements |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 9 2023 |
DOJ’s Antitrust Division Withdraws Healthcare Antitrust Policy Statements |
Bradley Arant Boult Cummings LLP |
| Feb 9 2023 |
EnforceMintz — 2022 Saw the Expansion of EKRA Outside of the Addiction Treatment Setting |
Mintz |
| Feb 9 2023 |
CMS and OIG Issue Guidance on Implementation of the Inflation Reduction Act |
ArentFox Schiff LLP |
| Feb 9 2023 |
2022 False Claims Act Enforcement Data Shows DOJ’s Continued Focus On Healthcare Fraud, Successful Year For Whistleblowers Who Go It Alone |
Barnes & Thornburg LLP |
| Feb 9 2023 |
EnforceMintz — 2022 Teed Up Two False Claims Act Issues That the Supreme Court Is Poised to Answer in 2023 |
Mintz |
| Feb 9 2023 |
CMS Releases New REH Conversion Guidance |
Nelson Mullins |
| Feb 9 2023 |
Justice Department Withdraws Policy Statements Concerning Health Care Information Exchanges |
Greenberg Traurig, LLP |
| Feb 9 2023 |
Podcast: Unpacking FDA’s Final Clinical Decision Support Guidance – Diagnosing Health Care [VIDEO] |
Epstein Becker & Green, P.C. |
| Feb 9 2023 |
Despite Some Setbacks, Enforcement Authorities Continue to Focus on the Opioid Supply Chain |
Mintz |
| Feb 9 2023 |
Federal Court Strikes Down Portions of the Final Rule Addressing the Independent Dispute Resolution Process Under the No Surprises Act |
Polsinelli PC |
| Feb 9 2023 |
NY Governor Proposes New Oversight of Transactions Involving Physician Practices, Other Health Care Entities |
Greenberg Traurig, LLP |
| Feb 9 2023 |
DOJ Antitrust Update Generates Uncertainty Surrounding Information Sharing And Transactions In The Healthcare Industry |
Barnes & Thornburg LLP |
| Feb 9 2023 |
The Vanishing Safety Zone: DOJ Withdraws Long-Established Healthcare and Information Sharing Guidelines with Far-Reaching Implications |
Godfrey & Kahn S.C. |
| Feb 8 2023 |
Trending in Telehealth: January 24, 2023 – February 5, 2023 |
McDermott Will & Schulte LLP |
| Feb 8 2023 |
CMS May Soon Be Asking: "When Did You Know?" As it Proposes Revisions to the Medicare 60-Day Overpayment Rule |
Dinsmore & Shohl LLP |
| Feb 8 2023 |
ICYMI: HIPAA and Social Media IRL |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 8 2023 |
DOJ Withdraws Long-Standing Support for Antitrust Enforcement Policy Statements in Health Care |
Epstein Becker & Green, P.C. |
| Feb 8 2023 |
Web Tracking Creates a Web of Data Privacy Risks |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 8 2023 |
The Long-Awaited End of the Tolling of Plan Deadlines due to COVID-19 |
Proskauer Rose LLP |
| Feb 8 2023 |
No Surprises Act and Three Takeaways on Surprise Billing |
McDermott Will & Schulte LLP |
| Feb 8 2023 |
DOJ Withdraws Key Healthcare Antitrust Enforcement Guidance: Where to Go From Here? |
Dinsmore & Shohl LLP |
| Feb 8 2023 |
“First-of-Its-Kind” FTC Breach Enforcement Case on Hot-Button Website Tracking Issue |
Polsinelli PC |
| Feb 8 2023 |
Employers Prepare for Thawing ERISA Deadlines |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Feb 8 2023 |
District Court Declares Portion of Regulations Governing NSA’s Dispute Resolution Process Invalid |
Squire Patton Boggs (US) LLP |
| Feb 7 2023 |
Out with the Old: The Antitrust Division Withdraws Healthcare Enforcement Policy Statements |
Mintz |
| Feb 7 2023 |
Public Health Emergency Ends May 11: What Telehealth Companies Need to Know |
Foley & Lardner LLP |
| Feb 7 2023 |
California Privacy Protection Agency Board Adopts and Approves CCPA Regulations and Discusses Preliminary Rulemaking for Cybersecurity Audits, Risk Assessments, and Automated Decision-Making |
Epstein Becker & Green, P.C. |
| Feb 7 2023 |
FTC Brings Enforcement Action under FTC Act and Health Breach Notification Rule Based on GoodRx’s Use of Advertising Tracking Technology on Its Websites and Mobile Application |
Epstein Becker & Green, P.C. |
| Feb 6 2023 |
This Week in 340B: January 31 – February 6, 2023 |
McDermott Will & Schulte LLP |
| Feb 6 2023 |
Department of Justice Withdraws Key Healthcare Antitrust Policy Statements |
Sheppard, Mullin, Richter & Hampton LLP |
| Feb 6 2023 |
Federal Communications Commission Authorizes Use of Automated and Prerecorded Voice Technology Outreach for Certain Health Policy Renewals |
Squire Patton Boggs (US) LLP |
